Alexis Peyroles
Directeur Général chez Ose Immunotherapeutics, Inc.
Fortune : 8 M $ au 31/05/2024
Postes actifs de Alexis Peyroles
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Aperana Consulting SAS | Président | - | - |
| Ose Immunotherapeutics, Inc. | Directeur Général | - | - |
Historique de carrière de Alexis Peyroles
Anciens postes connus de Alexis Peyroles
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Directeur/Membre du Conseil | 01/05/2016 | 16/01/2022 |
| Directeur Général | 12/04/2018 | 16/01/2022 | |
| Directeur des opérations | 01/05/2016 | 12/04/2018 | |
| Guerbet Imagem do Brasil Ltda. | Directeur Général | 01/01/2009 | - |
| Sanofi-Aventis Japan | Comptroller/Controller/Auditor | 01/01/1996 | - |
| GUERBET | Comptroller/Controller/Auditor | 01/01/2005 | - |
Sanofi-Aventis France SA
 Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Corporate Officer/Principal | 01/01/1996 | - |
Orphan Synergy Europe-Pharma SA
 Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Directeur Financier/CFO | 01/09/2013 | - |
Formation de Alexis Peyroles
| École des Hautes Études Commerciales du Nord | Undergraduate Degree |
| Imperial College Business School | Masters Business Admin |
Statistiques
Internationale
| France | 7 |
| Etats-Unis | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Chief Executive Officer | 3 |
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GUERBET | Health Technology |
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Entreprise privées | 6 |
|---|---|
Orphan Synergy Europe-Pharma SA
Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Health Technology |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Distribution Services |
| Aperana Consulting SAS | |
| Ose Immunotherapeutics, Inc. | |
| Sanofi-Aventis Japan | |
| Guerbet Imagem do Brasil Ltda. |
- Bourse
- Insiders
- Alexis Peyroles
- Expérience
